TENAX THERAPEUTICS, INC.(TENX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $1.9M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
TENX Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for TENAX THERAPEUTICS, INC. (TENX), a Healthcare sector company. TENX is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $1.9m in revenue and is scored on the micro-cap board instead. Top institutional holders of TENX by reported 13-F value include FMR, Vivo Capital, BlackRock, based on the most recent SEC filings. TENX trades on the Nasdaq exchange and files with the SEC under CIK 34956. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TENX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TENAX THERAPEUTICS, INC. directly from SEC EDGAR.
Revenue
Q2 2026
$0.00
Net Income
Q2 2026
$-17.8M
ROIC
Q2 2026
-66.1%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
Net Income
-198.8% YoYOperating Income
-189.2% YoYEPS (Diluted)
-16.5% YoYTotal Assets
+7.8% YoYOp. Cash Flow
-141.7% YoYFree Cash Flow
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | — | — | — | — |
| Net Income | $-52.6M -198.8% | $-17.6M -128.3% | $-7.7M -169.8% | $11.0M +134.0% | $-32.5M -229.6% | $-9.9M |
| Operating Income | $-56.4M -189.2% | $-19.5M -136.8% | $-8.2M -174.5% | $11.1M +133.8% | $-32.7M -231.7% | $-9.9M |
| EPS (Diluted) | $-1.34 -16.5% | $-1.15 +96.3% | $-31.04 | — | — | — |
| Total Assets | $104.2M +7.8% | $96.7M +727.5% | $11.7M +243.2% | $3.4M -43.2% | $6.0M -12.8% | $6.9M |
| Operating Cash Flow | $-35.8M -141.7% | $-14.8M -150.9% | $-5.9M +48.2% | $-11.4M -4.9% | $-10.9M -17.1% | $-9.3M |
| Free Cash Flow | — | — | — | $-11.4M -4.9% | $-10.9M -17.1% | $-9.3M |
Get alerted when TENX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for TENAX THERAPEUTICS, INC. including:
Top Institutional Holders of TENX
FMR LLC
$57.4M3,942,373 shVivo Capital, LLC
$36.4M2,500,000 shBlackRock, Inc.
$25.1M1,727,988 shPERCEPTIVE ADVISORS LLC
$24.7M1,700,000 shVANGUARD CAPITAL MANAGEMENT LLC
$16.7M1,147,121 shMILLENNIUM MANAGEMENT LLC
$12.7M876,230 shIkarian Capital, LLC
$11.5M787,600 shCandriam S.C.A.
$10.9M749,588 shCITADEL ADVISORS LLC
$10.6M728,561 shRTW INVESTMENTS, LP
$10.1M696,570 sh
| Fund | Value | Shares |
|---|---|---|
| FMR LLC | $57.4M | 3,942,373 |
| Vivo Capital, LLC | $36.4M | 2,500,000 |
| BlackRock, Inc. | $25.1M | 1,727,988 |
| PERCEPTIVE ADVISORS LLC | $24.7M | 1,700,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | $16.7M | 1,147,121 |
| MILLENNIUM MANAGEMENT LLC | $12.7M | 876,230 |
| Ikarian Capital, LLC | $11.5M | 787,600 |
| Candriam S.C.A. | $10.9M | 749,588 |
| CITADEL ADVISORS LLC | $10.6M | 728,561 |
| RTW INVESTMENTS, LP | $10.1M | 696,570 |
More Healthcare Companies
View all Healthcare →Put TENX on your watchlist
Track score changes the day TENAX THERAPEUTICS, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is TENX a good stock to buy?
13F Pro's AI-powered analysis of TENAX THERAPEUTICS, INC. (TENX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for TENX are available on the TENX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. TENX is classified as a small company.
Which hedge funds own TENX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling TENX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of TENAX THERAPEUTICS, INC.'s investment landscape.